Company Overview of Arsenal Capital Partners
Arsenal Capital Partners is a private equity firm specializing in buyout, recapitalization, and growth equity investments in the lower middle market companies. The firm typically invests in healthcare, specialty industrial, integration enabler and advisor, and financial services companies. Within healthcare, it focuses on manufacturing and service companies within pharmaceutical, medical devices, and healthcare services markets such as contract research, manufacturing, and testing services, medical and diagnostic devices and supplies, specialty distribution and logistics, alternative site care providers, healthcare information technology, pediatrics, and outsourced services to payors and pro...
100 Park Avenue
New York, NY 10017
Founded in 2000
Key Executives for Arsenal Capital Partners
Chief Financial Officer and Chief Compliance Officer
Partner and Member of Operating Committee
Compensation as of Fiscal Year 2014.
Arsenal Capital Partners Key Developments
Arsenal Capital Reportedly Considers Alternatives For Royal Adhesives
Jul 15 14
Arsenal Capital Partners is exploring strategic alternatives for Royal Adhesives and Sealants LLC, Wall Street Journal reported citing people familiar with the matter. Credit Suisse Group AG (SWX:CSGN) is believed to help Arsenal Capital Partners. Royal Adhesives and Sealants LLC could fetch about 10 times its $100 million in annual earnings before interest, taxes, depreciation and amortization or $1 billion including debt, in a sale, people added.
Arsenal Capital Partners Presents at 7th Annual SuperReturn U.S. conference, Jun-09-2014 through Jun-12-2014
Jun 9 14
Arsenal Capital Partners Presents at 7th Annual SuperReturn U.S. conference, Jun-09-2014 through Jun-12-2014. Venue: Renaissance Boston Waterfront Hotel, 606 Congress Street, Boston, MA 02210, United States. Presentation Date & Speakers: Jun-10-2014, Terrence M. Mullen, Co-founder, Partner and Member of Operating Committee. Jun-12-2014, Terrence M. Mullen, Co-founder, Partner and Member of Operating Committee.
Arsenal Capital Partners Announces Appointment of Frank Scrudato as Chief Financial Officer and Chief Compliance Officer
Feb 13 14
Arsenal Capital Partners announced the appointment of Frank Scrudato as Chief Financial Officer and Chief Compliance Officer. Mr. Scrudato was formerly Chief Financial Officer and Principal of Bruckmann, Rosser, Sherrill & Co. Pilar Lorente, Arsenal's Chief Financial Officer since 2006, will continue to assist the firm on an ongoing basis with finance and compliance projects. In addition, Ms. Lorente will advise small businesses and investment firms on finance and compliance issues.
Similar Private Companies By Industry
Recent Private Companies Transactions